Skip to content

Webinar
The new AHA guidelines // The evolving consensus on stroke imaging
March 24, 3:00 PM PT

Register
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
Press Release

RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification

RapidAI announced that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism.

Share to

RapidAI announced that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism.

San Mateo, Calif. — May 24 , 2022 — RapidAI , the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism — further strengthening RapidAI’s industry-leading clinical AI platform. New research shows that death rates for pulmonary embolism have been on the rise over the last decade , with the biggest increase among people under 65. For those who experience and survive a PE incident, one-third will have a recurrence within 10 years . Increasing access to clinically validated technology will be key to helping hospitals more efficiently coordinate care, make accurate diagnoses in a timely manner, and get PE patients to treatment faster, leading to better outcomes. “Building on our expertise in stroke, we’re confident this technology will help modernize PE care and meaningfully improve patient outcomes,” said Karim Karti, CEO of RapidAI. “Our goal is to build solutions that address the specific challenges associated with treating various conditions, as well as the communication and workflow issues faced by hospitals globally. From stroke to aneurysm to PE, we’re proud of how much RapidAI has grown and are excited to continue to redefine the patient care journey.” Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE , will enable care teams to more easily manage the entire patient care journey, from the moment a suspected PE patient is identified to diagnosis and through treatment. By automatically identifying a suspected pulmonary embolism and delivering real-time notifications to physicians, patients can be triaged faster and care teams aligned more quickly, reducing overall time to treatment. “I’m excited to see first-hand how artificial intelligence will transform the way we triage and manage PE, a historically complicated process involving a diverse care team,” said Dr. Jimmy Kerrigan, an Interventional Cardiologist at Ascension St. Thomas Heart. “After seeing what RapidAI technology has done for stroke, I’m optimistic about its potential to optimize our care for patients and to hopefully improve patient outcomes.” Join us at SIR’s 2022 Annual Scientific Meeting , Booth #346, to learn more about RapidAI clinically-validated solutions, and see a product demonstration of Rapid PE. About RapidAI RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Empowering physicians to make faster decisions for better patient outcomes, RapidAI is leading the next evolution of clinical decision-making and patient workflow. Based on intelligence gained from over 5 million scans in more than 2,000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com

Get to know Rapid in the real world

View All Resources
Video - Lumina Webinar Replay

Webinar

The end of manual head & neck reconstructions // A faster path with Lumina 3D

In this webinar, we focus on the challenges and opportunities in 3D head and neck CTA reconstruction workflows. Our speakers share real-world insights on how the Lumina 3D platform can have a tangible impact on CT workflow, scanner throughput, and diagnosis.
Radiology Rewired Podcast - Episode 1 Thumbnail

Podcast

AI Meets Imaging | Radiology Rewired | Ep. 1

In the debut episode of Radiology Rewired, RapidAI’s new clinician-led podcast hosted by Dr. Singh, Dr. Greg Albers—founder of RapidAI and professor of neurology at Stanford University—shares the story behind one of medicine’s most important breakthroughs: extending the stroke treatment window to 24 hours. Dr. Albers recounts how decades of imaging research led from early diffusion-perfusion MRI to automated AI tools that changed global stroke guidelines and transformed how teams diagnose and treat patients. This episode explores how deep clinical AI is reshaping radiology and why credible, clinician-led innovation remains essential for the next generation of healthcare technology.
Resources - multistakeholder white paper

White paper

The clinical AI champion's guide: getting to "yes" in complex health systems

This guide is designed for internal champions, clinicians, service line leaders, and administrators who believe in the potential of AI to improve care and operations. It offers practical insights from a C-suite advisory panel from leading health systems across the nation on how decisions are made, who typically drives them forward, and what tools and strategies are proving most effective in securing alignment and buy-in across the system.